Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Oxford BioDynamics PLC - Oxford, England-based biotechnology company that develops medical tests - Announces collaboration with Google Cloud to support the development and deployment of Oxford Biodynamics’s analytical framework on the cloud. Google Cloud will provide support via cloud computing, enabling Oxford Biodynamics to scale its proprietary EpiSwitch knowledge space and analytical tools and deliver high-throughput, artificial intelligence-powered 3D genomic analytics in a secure and efficient environment, aimed at helping pharma and biotech partners.
Oxford Biodynamics Executive Chair Iain Ross says: ‘We are excited to develop a powerful and interoperable platform that aligns with the future of cloud-native biomedical research. Google Cloud’s global infrastructure allows us to share insights faster, collaborate more easily with our partners, and bring our predictive genomic tools into clinics and labs around the world - at scale.’
Current stock price: 0.42 pence each, up 13% on Wednesday afternoon in London
12-month change: down 94%
Copyright 2025 Alliance News Ltd. All Rights Reserved.